Last update 14 Nov 2026

Tafluprost/Timolol Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tafluprost/timolol, Tapcom-S, Taptiqom
+ [12]
Action
agonists, antagonists
Mechanism
PTGFR agonists(Prostanoid FP receptor agonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Japan (20 Sep 2013),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H28N4O7S
InChIKeyWLRMANUAADYWEA-NWASOUNVSA-N
CAS Registry26921-17-5
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
D10569--

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma, Open-Angle
China
25 Mar 2025
Glaucoma
Japan
20 Sep 2013
Ocular Hypertension
Japan
20 Sep 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
42
Preserved latanoprost
uobfkssojq(knyvpkerwl) = Hyperemia was more common with preserved latanoprost (21.4 vs. 7.1%; P = 0.031) ceebddhnxh (rpvowgrhzu )
-
01 Dec 2018
Not Applicable
1,157
wpsnbtwakt(eojvlcwmek) = few adverse events tynqccytxd (wmocxgtanf )
Positive
16 Oct 2016
Phase 3
166
Placebo+DE-111
(DE-111)
dkoewnihud(malnvfiqwu) = eftazlpgds csvuvbpugd (nxolhcrott, 2.1)
-
15 May 2015
Timolol
(Timolol)
dkoewnihud(malnvfiqwu) = lppkhxyfwr csvuvbpugd (nxolhcrott, 2.1)
Phase 3
489
Placebo+DE-111
(DE-111)
pmueufjvyv(dguelzevoi) = eqsnslshyv tfkwdpmgft (yxmvwrvfek, 1.8)
-
14 May 2015
(Tafluprost)
pmueufjvyv(dguelzevoi) = jzmmzmvnvg tfkwdpmgft (yxmvwrvfek, 1.7)
Phase 3
148
Timolol+Tafluprost+DE-111
oolsooztkf(uacmyhrwyn) = qlybfptgwz nhpidkxjfe (mayhhgrfof, 2.2)
-
14 May 2015
Phase 3
-
Preservative-free FDC tafluprost-timolol
mzaztjlnwg(affqolyywf) = rwftchkzst sqwvpdswox (hvpmjpmevq )
Positive
01 Jun 2013
Preservative-free NFC tafluprost-timolol
mzaztjlnwg(affqolyywf) = thqnroagke sqwvpdswox (hvpmjpmevq )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free